🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An evaluation of long term safety of repeat ALD403 doses in Chronic Migrain...
Status
Completed
Location
Research Site
Start Date
2016-12
Trial ID
NCT02985398
Treatments Being Tested
The purpose of the study is to investigate how the body absorbs, distribute...
Status
Completed
Location
New England Institute for Clinical Research
Start Date
2020-08-04
Trial ID
NCT04537429
Treatments Being Tested
The goal of this observational study is to evaluate clinical differences in...
Status
Recruiting
Location
University of Miami, Miller School of Medicine
Start Date
2024-01-02
Trial ID
NCT07159750
Treatments Being Tested
The main purpose of this study is to compare the change in pain intensity d...
Status
Withdrawn
Location
Mayo Clinic Minnesota
Start Date
2025-01
Trial ID
NCT05937152
Treatments Being Tested
The object of this study is to assess the effectiveness, safety, and tolera...
Status
Recruiting
Location
IRCCS San Raffaele Roma
Start Date
2023-01-01
Trial ID
NCT05570149
This research study is designed as a longitudinal prospective descriptive s...
Status
Completed
Location
King Chualongkorn Memorial Hospital, the Thai Red Cross Society
Start Date
2025-08-25
Trial ID
NCT07035197
Treatments Being Tested
Approved by the Food and Drug Administration (FDA) and the European Medicin...
Status
Recruiting
Location
Istituto Auxologico Italiano IRCCS
Start Date
2022-03-24
Trial ID
NCT07103694
Treatments Being Tested
The main goal of this trial is to learn whether eptinezumab improves migrai...
Status
Active Not Recruiting
Location
Neuropain Medical Center
Start Date
2024-12-18
Trial ID
NCT06701526
Treatments Being Tested
The purpose of the study is to investigate how a medication called eptinezu...
Status
Unknown
Location
Royal Columbian Hospital
Start Date
2024-09-30
Trial ID
NCT06428838
Treatments Being Tested
The main goal of this trial is to learn whether eptinezumab helps reduce th...
Status
Recruiting
Location
Ki Health Partners LLC DBA New England Institute for Clinical Research
Start Date
2023-06-08
Trial ID
NCT05897320
Treatments Being Tested